These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 16181356

  • 1. Carbonic anhydrase, acetazolamide and Helicobacter pylori infection.
    Buzás GM.
    Helicobacter; 2005 Oct; 10(5):444. PubMed ID: 16181356
    [No Abstract] [Full Text] [Related]

  • 2. Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot study.
    Shahidzadeh R, Opekun A, Shiotani A, Graham DY.
    Helicobacter; 2005 Apr; 10(2):136-8. PubMed ID: 15810944
    [Abstract] [Full Text] [Related]

  • 3. Structural Basis for the Inhibition of Helicobacter pylori α-Carbonic Anhydrase by Sulfonamides.
    Modak JK, Liu YC, Machuca MA, Supuran CT, Roujeinikova A.
    PLoS One; 2015 Apr; 10(5):e0127149. PubMed ID: 26010545
    [Abstract] [Full Text] [Related]

  • 4. Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
    Nishimori I, Vullo D, Minakuchi T, Morimoto K, Onishi S, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2006 Apr 15; 16(8):2182-8. PubMed ID: 16459077
    [Abstract] [Full Text] [Related]

  • 5. Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
    Nishimori I, Minakuchi T, Kohsaki T, Onishi S, Takeuchi H, Vullo D, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2007 Jul 01; 17(13):3585-94. PubMed ID: 17482815
    [Abstract] [Full Text] [Related]

  • 6. Helicobacter pylori CAs inhibition.
    Bernardoni BL, La Motta C, Carradori S, D'Agostino I.
    Enzymes; 2024 Jul 01; 55():213-241. PubMed ID: 39222992
    [Abstract] [Full Text] [Related]

  • 7. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
    Nishimori I, Minakuchi T, Morimoto K, Sano S, Onishi S, Takeuchi H, Vullo D, Scozzafava A, Supuran CT.
    J Med Chem; 2006 Mar 23; 49(6):2117-26. PubMed ID: 16539401
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological inhibition of brain carbonic anhydrase protects against 4-aminopyridine seizures.
    Mihály A, Bencsik K, Nógrádi A.
    Acta Physiol Hung; 1994 Mar 23; 82(2):99-108. PubMed ID: 7887180
    [Abstract] [Full Text] [Related]

  • 9. [Topical carbonic anhydrase inhibitors for glaucoma].
    Geyer O, Michaeli-Cohen A.
    Harefuah; 1996 May 15; 130(10):705-7. PubMed ID: 8794665
    [No Abstract] [Full Text] [Related]

  • 10. Novel carbonic anhydrase inhibitors for the treatment of Helicobacter pylori infection.
    Supuran CT.
    Expert Opin Investig Drugs; 2024 May 15; 33(5):523-532. PubMed ID: 38517734
    [Abstract] [Full Text] [Related]

  • 11. The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets.
    Nishimori I, Onishi S, Takeuchi H, Supuran CT.
    Curr Pharm Des; 2008 May 15; 14(7):622-30. PubMed ID: 18336307
    [Abstract] [Full Text] [Related]

  • 12. A comparison of the effectiveness of dorzolamide and acetazolamide in preventing post-operative intraocular pressure rise following phacoemulsification. 1999; 43 (5): 344-6.
    Chakraborty P, Villada JR, Tinu AT.
    J R Coll Surg Edinb; 1999 Dec 15; 44(6):411-2. PubMed ID: 10612969
    [No Abstract] [Full Text] [Related]

  • 13. Targeting carbonic anhydrase to treat diabetic retinopathy: emerging evidences and encouraging results.
    Weiwei Z, Hu R.
    Biochem Biophys Res Commun; 2009 Dec 18; 390(3):368-71. PubMed ID: 19833100
    [Abstract] [Full Text] [Related]

  • 14. Carbonic anhydrase inhibition in ophthalmology: carbonic anhydrases in cornea, lens, retina and lacrimal gland.
    Wistrand PJ.
    EXS; 2000 Dec 18; (90):413-24. PubMed ID: 11268527
    [No Abstract] [Full Text] [Related]

  • 15. Selective Inhibition of Helicobacter pylori Carbonic Anhydrases by Carvacrol and Thymol Could Impair Biofilm Production and the Release of Outer Membrane Vesicles.
    Grande R, Carradori S, Puca V, Vitale I, Angeli A, Nocentini A, Bonardi A, Gratteri P, Lanuti P, Bologna G, Simeone P, Capasso C, De Luca V, Supuran CT.
    Int J Mol Sci; 2021 Oct 27; 22(21):. PubMed ID: 34769015
    [Abstract] [Full Text] [Related]

  • 16. [Acetazolamide--are there reasons for its revival in antiepileptic treatment?].
    Hoddevik GH.
    Tidsskr Nor Laegeforen; 2000 Mar 30; 120(9):1042-5. PubMed ID: 10833964
    [Abstract] [Full Text] [Related]

  • 17. The periplasmic alpha-carbonic anhydrase activity of Helicobacter pylori is essential for acid acclimation.
    Marcus EA, Moshfegh AP, Sachs G, Scott DR.
    J Bacteriol; 2005 Jan 30; 187(2):729-38. PubMed ID: 15629943
    [Abstract] [Full Text] [Related]

  • 18. Cloning, purification and preliminary crystallographic analysis of the complex of Helicobacter pylori α-carbonic anhydrase with acetazolamide.
    Modak JK, Revitt-Mills SA, Roujeinikova A.
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Nov 30; 69(Pt 11):1252-5. PubMed ID: 24192362
    [Abstract] [Full Text] [Related]

  • 19. Acclimatizing with acetazolamide.
    Basnyat B.
    J Travel Med; 2012 Nov 30; 19(5):281-3. PubMed ID: 22943266
    [No Abstract] [Full Text] [Related]

  • 20. Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity.
    Supuran CT.
    Expert Opin Emerg Drugs; 2012 Mar 30; 17(1):11-5. PubMed ID: 22335448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.